BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 8088954)

  • 21. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system.
    Chaudhry A; Papanicolaou V; Oberg K; Heldin CH; Funa K
    Cancer Res; 1992 Feb; 52(4):1006-12. PubMed ID: 1310635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Baudouin C; Brignole F; Fredj-Reygrobellet D; Nègre F; Bayle J; Gastaud P
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2822-9. PubMed ID: 1382045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: evidence of an autocrine pathway of platelet-derived growth factor.
    Koyama N; Watanabe S; Tezuka M; Morisaki N; Saito Y; Yoshida S
    J Cell Physiol; 1994 Jan; 158(1):1-6. PubMed ID: 7505273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The involvement of platelet-derived growth factor receptors and insulin-like growth factor-I receptors signaling during mineralized nodule formation by human periodontal ligament cells.
    Nemoto E; Shimonishi M; Nitta Y; Shimauchi H
    J Periodontal Res; 2004 Dec; 39(6):388-97. PubMed ID: 15491343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy.
    Andrews A; Balciunaite E; Leong FL; Tallquist M; Soriano P; Refojo M; Kazlauskas A
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2683-9. PubMed ID: 10509666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subretinal membranes in proliferative vitreoretinopathy. An immunohistochemical study.
    García-Arumí J; Corcostegui B; Tallada N
    Retina; 1992; 12(3 Suppl):S55-9. PubMed ID: 1280852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
    Mori K; Gehlbach P; Ando A; Wahlin K; Gunther V; McVey D; Wei L; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1610-5. PubMed ID: 11980881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.
    Hermanson M; Funa K; Hartman M; Claesson-Welsh L; Heldin CH; Westermark B; Nistér M
    Cancer Res; 1992 Jun; 52(11):3213-9. PubMed ID: 1317261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
    Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
    Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ontogeny of platelet-derived growth factor receptor in fetal rat lung.
    Han RN; Liu J; Tanswell AK; Post M
    Microsc Res Tech; 1993 Dec; 26(5):381-8. PubMed ID: 8286784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction.
    Carrington L; McLeod D; Boulton M
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1210-6. PubMed ID: 10752962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells.
    Vinores SA; Henderer JD; Mahlow J; Chiu C; Derevjanik NL; Larochelle W; Csaky C; Campochiaro PA
    Exp Eye Res; 1995 Jun; 60(6):607-19. PubMed ID: 7641844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
    J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-derived growth factor: receptor expression in corneas and effects on corneal cells.
    Hoppenreijs VP; Pels E; Vrensen GF; Felten PC; Treffers WF
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):637-49. PubMed ID: 8449682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo.
    Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA
    J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Augustin AJ; Spitznas M; Koch F; Grus F; Böker T
    Ger J Ophthalmol; 1995 Jan; 4(1):47-51. PubMed ID: 7728110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.